The latest edition of the mhGAP guideline is the third iteration and aims to help countries address the growing challenges of mental, neurological and substance use (MNS) conditions. With 30 updated and 18 new recommendations, this edition includes a total of 90 recommendations that provide non-specialist health workers in low and middle-income countries with high-quality, timely, transparent, and evidence-based guidance to effectively treat and care for individuals with MNS conditions.
The mhGAP programme has been in operation for over 15 years and has received significant investment to ensure its success. The revised recommendations reflect years of research and best practices in the field of MNS treatment and care. This latest edition of the guideline is designed to help countries improve their ability to address MNS conditions and reduce the treatment gap.
The need for improved capacity to address MNS conditions is growing, as more people worldwide are affected by these conditions. The mhGAP guideline aims to assist countries in meeting this challenge by providing non-specialist health workers with the tools they need to deliver effective treatment and care for individuals with MNS conditions.
The revised recommendations are intended to ensure that mhGAP continues to provide high-quality, timely, transparent, and evidence-based guidance to support non-specialist health workers in low and middle-income countries in delivering treatment and care for individuals with MNS conditions. This latest edition of the guideline represents a significant step forward in addressing the challenges faced by people living with MNS conditions around the world.